- Investopedia•2 hours ago
Credit Suisse says Pfizer could find Bristol-Myers attractive.
- Investor's Business Daily•3 hours ago
Pfizer could boost its value by $5 billion in a takeover of Bristol-Myers, an analyst said Monday.
- Investopedia•3 hours ago
Pfizer's Xeljanz got marketing approval from the EC, both as a monotherapy and as a combo therapy.
PFE.MX : Summary for PFIZER INC. - Yahoo Finance
Pfizer Inc. (PFE.MX)
Mexico - Mexico Delayed Price. Currency in MXN
Add to watchlist
|Bid||639.01 x 600000|
|Ask||649.99 x 600000|
|Day's Range||638.30 - 639.00|
|52 Week Range||513.20 - 733.98|
|PE Ratio (TTM)||544.76|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|